A third dose of Moderna’s COVID-19 vaccine substantially improved protection for organ transplant recipients whose weak immune systems don't always rev up enough with the standard two shots, Canadian ...

Moderna says it is in the process of developing a single-shot vaccine that could serve as a COVID-19 booster shot and a flu shot. In a press release Thursday touting its fifth annual "R&D Day," ...

Moderna said on Tuesday its updated COVID-19 vaccine formulation elicited a strong immune response in all adults aged 65 and older, as well as in individuals aged 12 to 64 with at least one underlying ...

Moderna said Wednesday that its experimental mRNA-based seasonal flu vaccine generated a stronger immune response against four strains of the flu virus than a currently marketed vaccine in a Phase 3 ...

CVS Pharmacy and Walgreens are both now administering COVID-19 booster shots, but only for those with weakened immune systems. It comes after the Food and Drug Administration ruled that transplant ...

LOS ANGELES - The U.S. Food and Drug Administration has authorized an additional COVID-19 booster vaccine for people who have compromised immune systems as the highly contagious delta variant ...

April 7 (Reuters) - Moderna Inc (MRNA.O), opens new tab Chief Medical Officer Tal Zaks said on Wednesday the company should be able to provide a booster shot for protection against variants of the ...

Moderna (NASDAQ:MRNA) updated data from a Phase 4 clinical trial for its redesigned COVID-19 vaccine, noting that the mRNA-based shot branded as mNEXSPIKE led to more than a 15-fold increase in ...

COVID pivot at Davos, betting on personalised mRNA cancer therapies, new vaccine launches, and AI-led drug development to ...

The complaint alleges that Moderna used the patented fluorescent protein technology without permission during preclinical through phase III trials and for marketing purposes, claiming the technology ...